Prospective Evaluation of the Efficacy and Safety of Endoscopic Tissue Apposition
- Conditions
- Endoscopic SuturingEndoscopic ClippingTransoral Outlet ReductionBariatric EndoscopyEndoscopic Tissue AppositionEndoscopic Sleeve Gastroplasty
- Registration Number
- NCT03626194
- Lead Sponsor
- University of Colorado, Denver
- Brief Summary
This study is a prospective registry of patients undergoing endoscopic suturing and/or clip placement at our institution to assess the efficacy and safety of endoscopic tissue apposition.
1.1 Hypothesis: Endoscopic tissue apposition is efficacious and safe in the practice of gastrointestinal endoscopy.
1.2 Aims: To prospectively evaluate the efficacy and safety of Endoscopic Tissue Apposition in the practice of gastrointestinal endoscopy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Patients>18 years of age undergoing endoscopy for any of the following indications:
Indications for Tissue Apposition:
- Closure of perforations
- Closure of full thickness defects created during endoscopic full thickness resection
- Closure of defects after endoscopic submucosal dissection and endoscopic mucosal resection
- Closure of mucosotomy after Peroral Endoscopic Myotomy (POEM)
- Stent fixation
- Closure of fistulas
- Natural Orifice Transluminal Endoscopic Surgery defect closures
- Post-bariatric surgery gastrojejunal anastomosis and gastric pouch revision (transoral outlet repair)
- Primary endoscopic sleeve gastroplasty
- Patients unable or unwilling to provide consent
- Pregnant patients
- Coagulation disorders (INR >1.8, platelet <50,000)
- GI Bleeding
- Hemodynamic instability
- Enrollment in another device or drug study that may confound the results
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Technical and clinical success in endoscopic tissue apposition From baseline to one year Successful completion of endoscopic suturing/clipping and measured as clinical symptom improvement as well as objective evidence of resolution / improvement of underlying pathology / confirmed with radiologic contrast studies as needed..
Adverse Events From baseline to one year Based on ASGE criteria
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Colorado Hospital
🇺🇸Aurora, Colorado, United States